Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124853342 | 12485334 | 2 | F | 20160811 | 20160621 | 20160824 | EXP | FR-PFIZER INC-2016234220 | PFIZER | FORNECKER, L.. LEAM PROTOCOL (LOMUSTINE, ETOPOSIDE, ARA-C/CYTARABINE, MELPHALAN) AS HIGH-DOSE CHEMOTHERAPY (HDT) BEFORE AUTOLOGOUS STEM CELL TRANSPLANT (ASCT) FOR LYMPHOID MALIGNANCIES: A MONOCENTRIC EXPERIENCE. BONE MARROW TRANSPLANTATION. 2016;51 (1):S238-S239 | 66.00 | YR | F | Y | 0.00000 | 20160824 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124853342 | 12485334 | 1 | PS | CYTARABINE. | CYTARABINE | 1 | Intravenous (not otherwise specified) | 2000 MG/M2, 2X/DAY (DIVIDED OVER 4 D FROM D-6 TO -3) | 71868 | 2000 | MG/M**2 | BID | |||||||
| 124853342 | 12485334 | 2 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Intravenous (not otherwise specified) | 1600 MG/M2, 2X/DAY (DIVIDED OVER 4 D FROM D-6 TO -3) | 0 | 1600 | MG/M**2 | BID | |||||||
| 124853342 | 12485334 | 3 | SS | LOMUSTINE. | LOMUSTINE | 1 | Oral | 200 MG/M2, UNK (ON DAY (D) -7) | 0 | 200 | MG/M**2 | ||||||||
| 124853342 | 12485334 | 4 | SS | MELPHALAN | MELPHALAN | 1 | Intravenous (not otherwise specified) | 140 MG/M2, UNK (ON D-2) | 0 | 140 | MG/M**2 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124853342 | 12485334 | 1 | Diffuse large B-cell lymphoma |
| 124853342 | 12485334 | 2 | Diffuse large B-cell lymphoma |
| 124853342 | 12485334 | 3 | Diffuse large B-cell lymphoma |
| 124853342 | 12485334 | 4 | Diffuse large B-cell lymphoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124853342 | 12485334 | DE |
| 124853342 | 12485334 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124853342 | 12485334 | Mucosal inflammation | |
| 124853342 | 12485334 | Multiple organ dysfunction syndrome | |
| 124853342 | 12485334 | Pneumonia cryptococcal | |
| 124853342 | 12485334 | Venoocclusive liver disease |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |